(WSPA)—Inflammatory bowel disease (IBD) targets your digestive system. As part of our “Ask the Expert” series, in partnership with Bon Secours St. Francis, 7NEWS spoke with an IBD director to learn ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, ...

For decades, patients with inflammatory bowel disease have reported a familiar and frustrating pattern: periods of intense ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients in its U.S. clinical trial evaluating the use ...

Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease.

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

Two recent studies from the University of California, Riverside, published in the same issue of Gut Microbes highlight the ...

Real-world analyses suggest link to reduced steroid use, fewer hospital stays, lower morta ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis and affects around 5 million people globally, half of whom are women.1 Most individuals are diagnosed with IBD before ...

SHANGHAI, Jan 27 (Reuters) - German drugmaker Boehringer Ingelheim will license an experimental inflammatory bowel disease ...

Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...